See the DrugPatentWatch profile for lisdexamfetamine
Lisdexamfetamine, marketed under brand names like Vyvanse, has its patent exclusivity expiring. DrugPatentWatch.com tracks these patent expiries [1].
When Does Lisdexamfetamine's Patent Expire?
The primary patents protecting Vyvanse are set to expire. For example, U.S. Patent No. 7,465,800, which covers lisdexamfetamine dimesylate, has an expected expiry date in 2023 [2]. Other related patents also have expiration dates within the coming years.
What Happens When Lisdexamfetamine Patents Expire?
Once patent exclusivity ends, generic manufacturers can begin producing and marketing their own versions of lisdexamfetamine. This typically leads to increased competition and lower prices for the medication.
Can Generic Lisdexamfetamine Be Available Before Patent Expiry?
While patents are in place, generic entry is generally restricted. However, challenges to existing patents or the development of new formulations can sometimes lead to earlier market entry for generics or alternative treatments.
What Are the Risks Associated with Lisdexamfetamine?
Like all medications, lisdexamfetamine carries potential risks and side effects. These can include common issues such as decreased appetite, insomnia, and dry mouth. More serious side effects, though less common, can also occur and are detailed in prescribing information [3].
How Does Lisdexamfetamine Work?
Lisdexamfetamine is a prodrug of dextroamphetamine. It is converted to dextroamphetamine in the body after ingestion. Dextroamphetamine is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters, primarily dopamine and norepinephrine, in the brain. This mechanism helps to improve focus and control impulsivity in conditions like ADHD [3].
Are There Alternatives to Lisdexamfetamine?
Yes, several alternative medications are available for treating conditions like ADHD. These include other stimulant medications, such as methylphenidate-based drugs, and non-stimulant medications, each with different mechanisms of action and side effect profiles [3].
Who Makes Lisdexamfetamine?
The brand-name medication lisdexamfetamine (Vyvanse) is manufactured by Takeda Pharmaceutical Company [4]. Generic versions will be produced by various pharmaceutical companies following patent expiry.
How Much Does Lisdexamfetamine Cost?
The cost of lisdexamfetamine can vary significantly based on factors such as insurance coverage, pharmacy, and dosage. Brand-name Vyvanse is generally more expensive than potential future generic versions.
Where Can I Find More Information on Lisdexamfetamine Patents?
DrugPatentWatch.com provides detailed information on drug patents, including their expiration dates and legal status, for medications like lisdexamfetamine [1].
---
Sources:
[1] https://drugpatentwatch.com/
[2] https://drugpatentwatch.com/us/patent/7465800/
[3] Prescription information for Vyvanse
[4] Takeda Pharmaceutical Company website